发明名称 |
URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C. |
摘要 |
<p>Present application relates to the compounds of formula I useful to treat hepatitis C (HCV) infections. In the structure of the disclosed compounds is the uracil or thymine derivative linked via a phenylene into either fused 2-ring cyclic system (R6) or alternatively via additional two-atom linker (L) to a 5-6 membered monocycle (R6). Application further discloses polymorphs and pseudopolymorphs of two specific compounds: N-(6(3-t-butyl-5-(2>4-dioxo-3,4-dihydropyrimidin-1 (2H)- y!)2-methoxy-phenyl)naphthalen-2-yl)methanesulfonamide and (E)-N-(4(3-t- butyl-5-(2,4-dioxo-3)4-dihydropyrimidin-1 (2H)-yl)2-methoxy-styryl- phenyl)methanesulfonamide.</p> |
申请公布号 |
MX2010002905(A) |
申请公布日期 |
2010.07.05 |
申请号 |
MX20100002905 |
申请日期 |
2008.09.17 |
申请人 |
ABBOTT LABORATORIES. |
发明人 |
DAVID M. BARNES;JOHN K. PRATT;DAVID A. BETEBENNER;PAMELA L. DONNER;CLARENCE J. MARING;ROLF WAGNER;JOHN T. RANDOLPH;DAVID A. DEGOEY;CHARLES A. FLENTGE;PEGGY P. HUANG;DOUGLAS K. HUTCHINSON;ALLAN C. KRUEGER;RODGER F. HENRY;BRIAN J. KOTECKI;ANTHONY R. HAIGHT;YI GAO;KENT D. STEWART;KENTON L. LONGENECKER;TODD W. ROCKWAY;CHRISTOPHER E. MOTTER;MICHAEL D. TUFANO;DACHUN LIU;GEOFF G. Z. ZHANG;XIAOCHUN LOU;KATHY SARRIS;SHUANG CHEN;WARREN M. KATI;YAYA LIU;THADDEUS S. FRANCZYK II;JOHN E. HENGEVELD |
分类号 |
C07D239/22;A61K31/513;A61P31/12;C07D239/54;C07D401/10;C07D403/10;C07D409/10;C07D413/10;C07D417/10 |
主分类号 |
C07D239/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|